Investing Profile

Jonathan Silverstein


Executive Partner at OrbiMed

orbimed.comNew York, New York
Photo of Jonathan Silverstein, Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
OrbiMed Partner
$1M - $75.0M
CompanyStageDateRound SizeTotal Raised
Prevail Therapeutics
Series AMar 2018$75M
Series BNov 2017$40M
Venture RoundOct 2017$74M
Co-investors: James Blair (Domain Associates)
Audentes Therapeutics
Series COct 2015$65M
Series BDec 2014$43M
Co-investors: Stephen Squinto (OrbiMed), Kush Parmar (5am Ventures), Jonathan Leff (Deerfield Management)
Series FFeb 2013$30M
Series EFeb 2011$30M
Series DAug 2008$35M
Co-investors: Paul Madera (Meritech Capital Partners), Gil Kliman (InterWest)
Venture RoundOct 2012$2.6M
Series CAug 2012$80M
Private Equity RoundJul 2012$62M
Series BAug 2011$70M
Series BSep 2010$70M
Roka Bioscience
Series DJan 2012$48M
Series CJul 2011$20M
Co-investors: Josh Bilenker (Aisling Capital), James Barrett
Debt FinancingSep 2010$15M
Series BJun 2005$27M
Co-investors: Zeev Binman (Pitango Venture Capital)
Co-Founder The Silverstein Foundation for Parkinson's with GBA2017 - Present
Co-Head of Private Equity and General Partner OrbiMed Advisors1999 - Present
University of San Diego Doctor of Law (JD) and MBA
Denison University Bachelor's degree Economics